Last reviewed · How we verify
NCT05922202: FrCVCOPD
Influence of Frailty on Cardiovascular Events and Mortality in Patients With COPD.
trial testing Assessment of cardiovascular events, cardiovascular mortality, all-cause mortality, and mortality due to COPD at 12 and 24 months in Role of Frailty in COPD in 300 participants. Currently enrolling.
15 November 2025
Quick facts
| Lead sponsor | Azienda Ospedaliero-Universitaria di Modena |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 23 February 2024 |
| Primary completion | 15 November 2025 |
| Estimated completion | 30 June 2026 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Assessment of cardiovascular events, cardiovascular mortality, all-cause mortality, and mortality due to COPD at 12 and 24 months
Conditions studied
- Role of Frailty in COPD — all drugs for Role of Frailty in COPD →
Sponsor
Azienda Ospedaliero-Universitaria di Modena — full company profile →
Who can join
40 and older, any sex, with Role of Frailty in COPD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Observational study on the influence of frailty on cardiovascular risk in COPD.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Influence of frailty on cardiovascular events and mortality in patients with Chronic Obstructive Pulmonary Disease (COPD): Study protocol for a multicentre European observational study.
Verduri A, Clini E, Carter B, Hewitt J. · · 2024 · cited 2× · PMID 38917212 · DOI 10.1371/journal.pone.0300945 -
Influence of frailty on cardiovascular events and mortality in patients with Chronic Obstructive Pulmonary Disease (COPD): Study Protocol for a multicentre European observational study
Verduri A, Clini E, Carter B, Hewitt J. · · 2024 · DOI 10.1101/2024.03.10.24304053
Verify or expand the search:
- PubMed search for NCT05922202
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Azienda Ospedaliero-Universitaria di Modena trials
Trials by the same sponsor.
- NCT06913530 — European Multicentre Study of Long-term Results Following Visceral Arteries Revascularization: the E-VisAR Study · not yet recruiting
- NCT06883890 — Extended LH Administration · Phase 2 · not yet recruiting
- NCT07245537 — ENDOGYM: A Holistic Approach With Pelvic Floor Physiotherapy and Yoga for Endometriosis Pain Relief · completed
- NCT06236568 — Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation · NA · recruiting
- NCT06595212 — Genetics and Environment iNtersection In the ALS-FTD Spectrum: an Italian Twins Cohort studY With a Multi-Omics Approach · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05922202 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero-Universitaria di Modena
- Last refreshed: 5 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05922202.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing